Department of Cardiology B, Aarhus University Hospital, Aarhus, Denmark.
Am J Cardiol. 2009 Dec 15;104(12):1641-6. doi: 10.1016/j.amjcard.2009.07.037.
Accelerated idioventricular rhythm (AIVR) has been considered a marker of successful reperfusion in fibrinolytic-treated patients. Evidence is limited regarding its significance in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PPCI). The purpose of the present study was to determine the prevalence and associated outcomes of arrhythmias and conduction disturbances occurring during PPCI. In 503 patients with ST-elevation myocardial infarction, the arrhythmias and conduction disturbances occurring from arrival at the catheterization laboratory to 90 minutes after PPCI were registered. Continuous ST-monitoring was performed to determine the interval from the first wire to complete ST resolution. The area at risk was evaluated in the acute phase and the final infarct size (FIS) after 1 month using myocardial perfusion imaging. Mortality was registered at a median follow-up of 2.9 years. The most common arrhythmias observed during PPCI were AIVR (42%), sinus bradycardia (28%), and nonsustained ventricular tachycardia (26%). The arrhythmias associated with the FIS included AIVR (unstandardized regression coefficient [B] = 5.27, p <0.001), sustained ventricular tachycardia (B = 15.7, p <0.001), and sinus bradycardia (B = -4.12, p = 0.001). Right bundle branch block was the only conduction disturbance associated with FIS (B = 7.17, p = 0.001). Patients with AIVR less often achieved spontaneous ST resolution before PPCI (13% vs 36%, p <0.001), less often had Thrombolysis In Myocardial Infarction flow 3 on admission (3% vs 33%, p <0.001), had a larger area at risk (35% vs 23% of the left ventricle, p <0.001), had a longer time to complete ST resolution (39 vs 21 minutes, p <0.001), had a larger FIS (13% vs 5% of the left ventricle, p <0.001) but had similar mortality (8.6% and 6.5%, p = 0.39) compared to patients without AIVR. In conclusion, AIVR is the most frequent arrhythmia occurring during PPCI in patients with ST-elevation myocardial infarction. However, it is not a marker of successful reperfusion but is associated with extensive myocardial damage and delayed microvascular reperfusion.
加速性室性自主节律(AIVR)被认为是纤维蛋白溶解治疗患者再灌注成功的标志物。在接受直接经皮冠状动脉介入治疗(PPCI)的 ST 段抬高型心肌梗死患者中,其意义的证据有限。本研究的目的是确定在接受 PPCI 期间发生的心律失常和传导障碍的发生率及其相关结局。在 503 例 ST 段抬高型心肌梗死患者中,记录了从到达导管室到 PPCI 后 90 分钟期间发生的心律失常和传导障碍。连续 ST 监测用于确定从第一根导丝到完全 ST 段缓解的时间间隔。在急性期评估危险区,并在 1 个月后使用心肌灌注成像评估最终梗死面积(FIS)。中位随访 2.9 年后记录死亡率。在 PPCI 期间观察到的最常见心律失常是 AIVR(42%)、窦性心动过缓(28%)和非持续室性心动过速(26%)。与 FIS 相关的心律失常包括 AIVR(未标准化回归系数[B]=5.27,p<0.001)、持续性室性心动过速(B=15.7,p<0.001)和窦性心动过缓(B=-4.12,p=0.001)。右束支传导阻滞是唯一与 FIS 相关的传导障碍(B=7.17,p=0.001)。AIVR 患者在 PPCI 前较少自发达到 ST 段缓解(13% vs 36%,p<0.001),较少在入院时出现心肌梗死溶栓治疗(TIMI)血流 3(3% vs 33%,p<0.001),危险区更大(35% vs 23%的左心室,p<0.001),达到完全 ST 段缓解的时间更长(39 分钟 vs 21 分钟,p<0.001),FIS 更大(13% vs 5%的左心室,p<0.001),但死亡率相似(8.6%和 6.5%,p=0.39)与无 AIVR 的患者相比。总之,AIVR 是 ST 段抬高型心肌梗死患者接受 PPCI 时最常见的心律失常。然而,它不是再灌注成功的标志物,而是与广泛的心肌损伤和延迟的微血管再灌注有关。